Month: March 2021

Recently published: The AZALEA trial further supports suprachoroidal delivery f…

Recently published: https://t.co/zXdrj69jwc The AZALEA trial further supports suprachoroidal delivery for retinal disorders… #retina #eyes #ophthalmology #suprachoroidal #macula #clinicaltrials #clinicalresearch https://t.co/srVNk3jgpX Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Honored to moderate this very interesting #genetherapy panel…

RT @ThomasCiullaMD: Honored to moderate this very interesting #genetherapy panel discussion, now available via podcast… OIS Podcast Episo… Source by Thomas Ciulla, MD, MBA Return to main website.

Just published: Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene …


Just published: Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases

#eyes #retina #macula #GeneTherapy #AMD #diabeticretinopathy #suprachoroidal

https://t.co/Hkp7oE1XLp via @MDPIOpenAccess


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Recently published: Host immune responses after suprachoroid…

RT @ThomasCiullaMD: Recently published: Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes. https://t.co/ Source by Thomas Ciulla, MD, MBA Return to main website.

Honored to moderate this very interesting #genetherapy panel discussion, now ava…

Honored to moderate this very interesting #genetherapy panel discussion, now available via podcast… OIS Podcast Episode #269: KOLs Speak Out on the Future of Gene Therapy https://t.co/nXMnR91Btg via @YouTube Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ophthopedia: Ophthopedia Update: Suprachoroidal CLS-TA for non-infectious uv…


RT @ophthopedia: Ophthopedia Update: Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA) https://t.co/EY


Source by Thomas Ciulla, MD, MBA

Return to main website.